title: Burkholderia cepacia-an uncommon cause of exit-site infection in a peritoneal dialysis patient.
authors.affiliation: Division of Nephrology, Department of Medicine Queen Mary Hospital, The University of Hong Kong Hong Kong desmondy@hku.hk.
authors.forename: Desmond Y H
authors.initials: DY
authors.lastname: Yap
authors.affiliation: Division of Nephrology, Department of Medicine Queen Mary Hospital, The University of Hong Kong Hong Kong.
authors.forename: Cindy B Y
authors.initials: CB
authors.lastname: Choy
authors.affiliation: Division of Nephrology, Department of Medicine Queen Mary Hospital, The University of Hong Kong Hong Kong.
authors.forename: Maggie M Y
authors.initials: MM
authors.lastname: Mok
authors.affiliation: Division of Nephrology, Department of Medicine Queen Mary Hospital, The University of Hong Kong Hong Kong.
authors.forename: Tin Kan
authors.initials: TK
authors.lastname: Wong
authors.affiliation: Division of Nephrology, Department of Medicine Queen Mary Hospital, The University of Hong Kong Hong Kong.
authors.forename: Tak Mao
authors.initials: TM
authors.lastname: Chan
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019121:Burkholderia Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D016956:Burkholderia cepacia / Q000302:isolation & purification; D055499:Catheter-Related Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D002408:Catheters, Indwelling / Q000009:adverse effects / Q000382:microbiology*; D002442:Ceftazidime / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D010530:Peritoneal Dialysis / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D002442:Ceftazidime